Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 22, No 1 (January 1), 2004: pp. 39-44
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.06.128

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadley, D. W.
Right arrow Articles by Palmer, C. G.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadley, D. W.
Right arrow Articles by Palmer, C. G.S.

Colon Cancer Screening Practices After Genetic Counseling and Testing for Hereditary Nonpolyposis Colorectal Cancer

Donald W. Hadley, Jean F. Jenkins, Eileen Dimond, Maria de Carvalho, Ilan Kirsch, Christina G.S. Palmer

From the Genetic Counseling Research Unit, Medical Genetics Branch, National Human Genome Research Institute, and the Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; National Naval Medical Center, Bethesda, MD; and the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA

Address reprint requests to Donald W. Hadley, MS, CGC, GCRU/MGB/NHGRI/NIH, 10 Center Dr, MSC 1852, Bldg 10/Room 10 C103, Bethesda, MD 20892-1852; e-mail: dhadley{at}nhgri.nih.gov

PURPOSE: Hereditary nonpolyposis colorectal cancer (HNPCC) is the most common hereditary form of colon cancer. Cancer screening recommendations differ between individuals identified to carry an HNPCC mutation and those who do not carry a known family mutation. We assessed the impact of genetic counseling and testing (GCT) on the use of endoscopic screening procedures and adherence to recommended endoscopic screening guidelines in 56 asymptomatic at-risk individuals from families known to carry an HNPCC mutation.

PATIENTS AND METHODS: We analyzed data on colonoscopy and flexible sigmoidoscopy screenings collected before GCT and 6 months and 12 months post-GCT on 17 mutation-positive and 39 true mutation-negative individuals. Main outcome measures were use of endoscopic screening and adherence to recommended guidelines for the relevant mutation status. Mutation status, age, sex, employment, and income were analyzed as predictor variables.

RESULTS: Among mutation-negative individuals, use of colonoscopy and flexible sigmoidoscopy decreased significantly between pre- and post-GCT (P < .00001 and P < .0003, respectively). Among mutation-positive individuals, a nonsignificant increase (P = .24) in use was noted. Age was also associated with use of endoscopic screening after GCT (P = .03). Mutation status (odds ratio [OR], 7.5; P = .02) and employment (OR, 8.6; P = .025) were associated with nonadherence to endoscopic screening guidelines. More mutation-negative individuals strictly adhered to guidelines than did mutation-positive individuals (87% v 65%).

CONCLUSION: Genetic counseling and testing for HNPCC significantly influences the use of colonic endoscopy and adherence to recommendations for colon cancer screening.

Supported by the Medical Genetics Branch of the National Human Genome Research Institute, the Genetics Branch of the Center for Cancer Research within the National Cancer Institute, and by the 2002 Jane Engelberg Memorial Fellowship, an annual grant from the Engelberg Foundation to the National Society of Genetic Counselors Inc.

Authors' disclosures of potential conflicts of interest are found at the end of this article.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. G. Aspinwall, S. L. Leaf, E. R. Dola, W. Kohlmann, and S. A. Leachman
CDKN2A/p16 Genetic Test Reporting Improves Early Detection Intentions and Practices in High-Risk Melanoma Families
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1510 - 1519.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. W. Hadley, J. F. Jenkins, S. M. Steinberg, D. Liewehr, S. Moller, J. C. Martin, K. A. Calzone, P. W. Soballe, and I. R. Kirsch
Perceptions of Cancer Risks and Predictors of Colon and Endometrial Cancer Screening in Women Undergoing Genetic Testing for Lynch Syndrome
J. Clin. Oncol., February 20, 2008; 26(6): 948 - 954.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. M. Lindor, G. M. Petersen, D. W. Hadley, A. Y. Kinney, S. Miesfeldt, K. H. Lu, P. Lynch, W. Burke, and N. Press
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
JAMA, September 27, 2006; 296(12): 1507 - 1517.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. D. Ramsey, W. Burke, L. Pinsky, L. Clarke, P. Newcomb, and M. J. Khoury
Family History Assessment to Detect Increased Risk for Colorectal Cancer: Conceptual Considerations and a Preliminary Economic Analysis
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2494 - 2500.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online